StockData
Cardio Diagnostics Holdings, Inc. logo

Cardio Diagnostics Holdings, Inc. (CDIO) stock

CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.89+0.02 (+1.07%)

Close on Nov 13, 2026Market cap $5.59MP/E –Yield –

Cardio Diagnostics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Cardio Diagnostics's operating cash flow for the twelve months ending Sep 30, 2026 was -$5.78M. For fiscal 2025 it was -$5.73M. The highest annual figure on record is -$585.29K in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.73M–
FY2024Dec 31, 2024-$4.99M–
FY2023Dec 31, 2023-$5.67M–
FY2022Dec 31, 2022-$5.09M–
FY2021Dec 31, 2021-$585.29K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.52M–
Q2 FY2026Jun 30, 2026-$1.34M–
Q1 FY2026Mar 31, 2026-$1.56M–
Q4 FY2025Dec 31, 2025-$1.36M–
Q1 FY2025Mar 31, 2025-$1.40M–
Q4 FY2024Dec 31, 2024-$1.39M–
Q3 FY2024Sep 30, 2024-$1.16M–
Q2 FY2024Jun 30, 2024-$1.21M–
Q1 FY2024Mar 31, 2024-$1.23M–
Q4 FY2023Dec 31, 2023-$1.69M–
Q3 FY2023Sep 30, 2023-$1.04M–
Q2 FY2023Jun 30, 2023-$1.29M–
Q1 FY2023Mar 31, 2023-$1.65M–
Q2 FY2022Jun 30, 2022-$394.77K–
Q1 FY2022Mar 31, 2022-$186.09K–

More Cardio Diagnostics figures

See a number that looks wrong?